Literature DB >> 32475552

Polyglucosan body structure in Lafora disease.

M Kathryn Brewer1, Jean-Luc Putaux2, Alberto Rondon3, Annette Uittenbogaard3, Mitchell A Sullivan4, Matthew S Gentry5.   

Abstract

Abnormal carbohydrate structures known as polyglucosan bodies (PGBs) are associated with neurological disorders, glycogen storage diseases (GSDs), and aging. A hallmark of the GSD Lafora disease (LD), a fatal childhood epilepsy caused by recessive mutations in the EPM2A or EPM2B genes, are cytoplasmic PGBs known as Lafora bodies (LBs). LBs result from aberrant glycogen metabolism and drive disease progression. They are abundant in brain, muscle and heart of LD patients and Epm2a-/- and Epm2b-/- mice. LBs and PGBs are histologically reminiscent of starch, semicrystalline carbohydrates synthesized for glucose storage in plants. In this study, we define LB architecture, tissue-specific differences, and dynamics. We propose a model for how small polyglucosans aggregate to form LBs. LBs are very similar to PGBs of aging and other neurological disorders, and so these studies have direct relevance to the general understanding of PGB structure and formation.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lafora bodies; Lafora disease; epilepsy; glycogen; glycogen storage disease; polyglucosan bodies; starch

Mesh:

Substances:

Year:  2020        PMID: 32475552      PMCID: PMC7266828          DOI: 10.1016/j.carbpol.2020.116260

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  80 in total

1.  Amyloidosis: a convoluted story.

Authors:  R A Kyle
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998

2.  Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.

Authors:  Mitchell A Sullivan; Silvia Nitschke; Evan P Skwara; Peixiang Wang; Xiaochu Zhao; Xiao S Pan; Erin E Chown; Travis Wang; Ami M Perri; Jennifer P Y Lee; Francisco Vilaplana; Berge A Minassian; Felix Nitschke
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

3.  Phosphorylation of C6- and C3-positions of glucosyl residues in starch is catalysed by distinct dikinases.

Authors:  Gerhard Ritte; Matthias Heydenreich; Sebastian Mahlow; Sophie Haebel; Oliver Kötting; Martin Steup
Journal:  FEBS Lett       Date:  2006-08-10       Impact factor: 4.124

Review 4.  Lafora disease offers a unique window into neuronal glycogen metabolism.

Authors:  Matthew S Gentry; Joan J Guinovart; Berge A Minassian; Peter J Roach; Jose M Serratosa
Journal:  J Biol Chem       Date:  2018-02-26       Impact factor: 5.157

5.  Laforin and malin knockout mice have normal glucose disposal and insulin sensitivity.

Authors:  Anna A DePaoli-Roach; Dyann M Segvich; Catalina M Meyer; Yasmeen Rahimi; Carolyn A Worby; Matthew S Gentry; Peter J Roach
Journal:  Hum Mol Genet       Date:  2011-12-20       Impact factor: 6.150

Review 6.  The 5th International Lafora Epilepsy Workshop: Basic science elucidating therapeutic options and preparing for therapies in the clinic.

Authors:  Matthew S Gentry; Zaid Afawi; Dustin D Armstrong; Antonio Delgado-Escueta; Y Paul Goldberg; Tamar R Grossman; Joan J Guinovart; Frank Harris; Thomas D Hurley; Roberto Michelucci; Berge A Minassian; Pascual Sanz; Carolyn A Worby; Jose M Serratosa
Journal:  Epilepsy Behav       Date:  2020-01-10       Impact factor: 2.937

7.  Alkali-induced changes in functional properties and in vitro digestibility of wheat starch: the role of surface proteins and lipids.

Authors:  Shujun Wang; Heyang Luo; Jian Zhang; Yan Zhang; Zhonghu He; Shuo Wang
Journal:  J Agric Food Chem       Date:  2014-04-10       Impact factor: 5.279

8.  Structure of lintnerized starch is related to X-ray diffraction pattern and susceptibility to acid and enzyme hydrolysis of starch granules.

Authors:  Sathaporn Srichuwong; Naoto Isono; Takashi Mishima; Makoto Hisamatsu
Journal:  Int J Biol Macromol       Date:  2005-10-21       Impact factor: 6.953

9.  Nature of alpha and beta particles in glycogen using molecular size distributions.

Authors:  Mitchell A Sullivan; Francisco Vilaplana; Richard A Cave; David Stapleton; Angus A Gray-Weale; Robert G Gilbert
Journal:  Biomacromolecules       Date:  2010-04-12       Impact factor: 6.988

10.  Avoiding drying-artifacts in transmission electron microscopy: Characterizing the size and colloidal state of nanoparticles.

Authors:  Benjamin Michen; Christoph Geers; Dimitri Vanhecke; Carola Endes; Barbara Rothen-Rutishauser; Sandor Balog; Alke Petri-Fink
Journal:  Sci Rep       Date:  2015-05-12       Impact factor: 4.379

View more
  8 in total

Review 1.  Review: Neuropathology findings in autonomic brain regions in SUDEP and future research directions.

Authors:  Smriti Patodia; Alyma Somani; Maria Thom
Journal:  Auton Neurosci       Date:  2021-07-31       Impact factor: 3.145

2.  Lafora Disease and Alpha-Synucleinopathy in Two Adult Free-Ranging Moose (Alces alces) Presenting with Signs of Blindness and Circling.

Authors:  Madhu Ravi; Atilano Lacson; Margo Pybus; Mark C Ball
Journal:  Animals (Basel)       Date:  2022-06-25       Impact factor: 3.231

Review 3.  Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies.

Authors:  Kimberly Goodspeed; Rachel M Bailey; Suyash Prasad; Chanchal Sadhu; Jessica A Cardenas; Mary Holmay; Deborah A Bilder; Berge A Minassian
Journal:  Front Neurol       Date:  2022-06-21       Impact factor: 4.086

4.  Generation and characterization of a laforin nanobody inhibitor.

Authors:  Zoe R Simmons; Savita Sharma; Jeremiah Wayne; Sheng Li; Craig W Vander Kooi; Matthew S Gentry
Journal:  Clin Biochem       Date:  2021-04-05       Impact factor: 3.625

5.  Polyglucosan bodies in medullary catecholaminergic neurones in SUDEP.

Authors:  Smriti Patodia; Alyma Somani; Maria Thom
Journal:  Epilepsy Behav Rep       Date:  2021-01-28

Review 6.  TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases.

Authors:  Lorena Kumarasinghe; Lu Xiong; Maria Adelaida Garcia-Gimeno; Elisa Lazzari; Pascual Sanz; Germana Meroni
Journal:  Cells       Date:  2021-04-06       Impact factor: 6.600

7.  An empirical pipeline for personalized diagnosis of Lafora disease mutations.

Authors:  M Kathryn Brewer; Maria Machio-Castello; Rosa Viana; Jeremiah L Wayne; Andrea Kuchtová; Zoe R Simmons; Sarah Sternbach; Sheng Li; Maria Adelaida García-Gimeno; Jose M Serratosa; Pascual Sanz; Craig W Vander Kooi; Matthew S Gentry
Journal:  iScience       Date:  2021-10-13

Review 8.  Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease.

Authors:  Pascual Sanz; José Maria Serratosa; Marina P Sánchez
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.